<DOC>
	<DOCNO>NCT02285777</DOCNO>
	<brief_summary>This extension V102_16 study ( NCT02140762 ) . V102_16E1 design assess effectiveness 3-dose vaccination series MenABCWY , administer accord 0 , 2 , 6 month schedule , panel endemic US N. meningitidis serogroup B strain , measure enc-hSBA assay . The subject complete parent V102_16 study invite time last study visit participate extension study .</brief_summary>
	<brief_title>Assessing Effectiveness , Immunogenicity Safety Meningococcal ABCWY Vaccine Administered Healthy Adolescents</brief_title>
	<detailed_description />
	<mesh_term>Meningococcal Infections</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Adolescents complete V102_16 study receive study vaccine assign protocol ( either two dos MenABCWY one dose MenACWY Placebo ) . Serious , acute , chronic illness . Previous suspected disease cause N. meningitidis . History meningococcal vaccine administration vaccination give parent V102_16 protocol .</criteria>
	<gender>All</gender>
	<minimum_age>10 Years</minimum_age>
	<maximum_age>19 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>